Regulation of Central Nervous System Myeloid-Derived Suppressor Cells in the Crucial Role of Granulocytic
暂无分享,去创建一个
A. Sharpe | J. Matsoukas | D. Boumpas | P. Verginis | George Deraos | A. Plaitakis | A. Gravanis | V. Mastorodemos | M. Ioannou | T. Alissafi | I. Lazaridis
[1] A. Sharpe,et al. Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune Disease , 2012, The Journal of Immunology.
[2] T. Ratliff,et al. In vivo suppressive function of myeloid‐derived suppressor cells is limited to the inflammatory site , 2011, European journal of immunology.
[3] D. Gabrilovich,et al. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. , 2011, Trends in immunology.
[4] C. Divino,et al. Myeloid-Derived Suppressor Cells Prevent Type 1 Diabetes in Murine Models , 2010, The Journal of Immunology.
[5] J. Ochando,et al. Myeloid-derived suppressor cells: natural regulators for transplant tolerance. , 2010, Human immunology.
[6] Je-in Youn,et al. The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity , 2010, European journal of immunology.
[7] David H. Lee,et al. Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells , 2010, The Journal of Immunology.
[8] F. Ginhoux,et al. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. , 2010, The Journal of clinical investigation.
[9] S. Bicciato,et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. , 2010, Immunity.
[10] Loise M. Francisco,et al. The PD‐1 pathway in tolerance and autoimmunity , 2010, Immunological reviews.
[11] S. Sandwick,et al. Subsets, expansion and activation of myeloid-derived suppressor cells , 2010, Medical Microbiology and Immunology.
[12] Lawrence Steinman,et al. T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis , 2010, Nature Medicine.
[13] V. Bronte,et al. Myeloid-derived suppressor cell heterogeneity and subset definition. , 2010, Current opinion in immunology.
[14] E. Celis,et al. Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells , 2010, The Journal of Immunology.
[15] R. Strieter,et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. , 2010, The Journal of clinical investigation.
[16] C. Leclerc,et al. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. , 2009, Immunity.
[17] Je-in Youn,et al. Regulatory myeloid suppressor cells in health and disease. , 2009, Cancer research.
[18] G. Cheng,et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.
[19] A. Mildner,et al. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. , 2009, Brain : a journal of neurology.
[20] Irah L. King,et al. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. , 2009, Blood.
[21] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[22] A. Mildner,et al. CCR 2 + Ly-6 Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system , 2009 .
[23] M. McGeachy,et al. Cytokines that regulate autoimmunity. , 2008, Current opinion in immunology.
[24] A. Dick,et al. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. , 2008, Journal of autoimmunity.
[25] G. Bhagat,et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. , 2008, Cancer cell.
[26] J. Russell,et al. Regional CNS responses to IFN-γ determine lesion localization patterns during EAE pathogenesis , 2008, The Journal of experimental medicine.
[27] Michelle Collazo,et al. Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.
[28] M. Manns,et al. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. , 2008, Gastroenterology.
[29] V. Bronte,et al. Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells , 2008, Immunological reviews.
[30] G. Freeman,et al. PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.
[31] P. De Baetselier,et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. , 2008, Blood.
[32] J. Goverman,et al. Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells , 2008, Nature Medicine.
[33] M. Zöller,et al. The Importance of Myeloid-Derived Suppressor Cells in the Regulation of Autoimmune Effector Cells by a Chronic Contact Eczema1 , 2007, The Journal of Immunology.
[34] S. Youssef,et al. Type II monocytes modulate T cell–mediated central nervous system autoimmune disease , 2007, Nature Medicine.
[35] L. Moldawer,et al. MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis , 2007, The Journal of experimental medicine.
[36] G. Rabinovich,et al. Immunosuppressive strategies that are mediated by tumor cells. , 2007, Annual review of immunology.
[37] M. Leach,et al. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis , 2007, Journal of Neuroimmunology.
[38] V. Kuchroo,et al. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. , 2007, Journal of immunology.
[39] L. Steinman. Erratum: A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.
[40] M. Colombo,et al. The terminology issue for myeloid-derived suppressor cells. , 2007, Cancer research.
[41] Paolo Serafini,et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. , 2006, The Journal of clinical investigation.
[42] Hans Lassmann,et al. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.
[43] G. Freeman,et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance , 2006, The Journal of experimental medicine.
[44] Paolo Serafini,et al. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. , 2006, Seminars in cancer biology.
[45] C. Divino,et al. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. , 2006, Cancer research.
[46] J. Leips,et al. Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression1 , 2006, The Journal of Immunology.
[47] J. Chameau. Corrections , 2006, Nature.
[48] S. Segal,et al. CD11b+/Gr-1+ Immature Myeloid Cells Mediate Suppression of T Cells in Mice Bearing Tumors of IL-1β-Secreting Cells1 , 2005, The Journal of Immunology.
[49] L. A. Stephens,et al. Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System1 , 2005, The Journal of Immunology.
[50] L. Steinman,et al. Design of effective immunotherapy for human autoimmunity , 2005, Nature.
[51] T. Owens,et al. Neutrophils That Infiltrate the Central Nervous System Regulate T Cell Responses1 , 2005, The Journal of Immunology.
[52] R. Hohlfeld,et al. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[53] G. Freeman,et al. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[54] 津田 泰宏. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus , 2004 .
[55] O. Finn,et al. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. , 2001, Cancer research.
[56] R. Coffman,et al. Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.
[57] Nicholas R. English,et al. Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.
[58] S. Wittmer,et al. Failure to Suppress the Expansion of the Activated Cd4 T Cell Population in Interferon γ–Deficient Mice Leads to Exacerbation of Experimental Autoimmune Encephalomyelitis , 2000, The Journal of experimental medicine.
[59] J. Antel,et al. Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. , 2000, Journal of neuropathology and experimental neurology.
[60] H. Weiner,et al. IL-4-Deficient and Transgenic Mice Demonstrated by Studies of IL-10- and Autoimmune Encephalomyelitis as IL-10 Is Critical in the Regulation of , 1998 .
[61] W. Cowden,et al. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. , 1996, Journal of immunology.
[62] A. Billiau,et al. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon‐γ , 1996, European journal of immunology.
[63] L Steinman,et al. Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.
[64] L. Steinman,et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). , 1996, Journal of immunology.
[65] Meijuan Zhao,et al. Interferon-γ-Induced Oligodendrocyte Cell Death: Implications for the Pathogenesis of Multiple Sclerosis , 1995, Molecular medicine.
[66] R. Knobler,et al. Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. , 1993, Autoimmunity.
[67] R. Hirsch,et al. EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.
[68] J. Mussini,et al. [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.